Product
Benznidazole
Aliases
Abarax
Name
Benznidazole
INN Name
benznidazole
FDA Approved
Yes
7 clinical trials
1 organization
3 indications
1 document
Indication
Chagas DiseaseIndication
Safety IssuesIndication
Chronic Chagas DiseaseClinical trial
Phase III Randomized,Multicenter Non-inferiority Study to Evaluate the Efficacy and Safety of Shorter Benznidazole Regimens Compared to the Standard Regimen to Treat Adult Patients With Chronic Chagas DiseaseStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Prospective, Single-arm, Multicentre Study, Using a Historical Control, to Evaluate the Efficacy/Safety and Population Pharmacokinetics of Benznidazole in Children With Chronic Indeterminate Chagas DiseaseStatus: Active (not recruiting), Estimated PCD: 2027-08-30
Clinical trial
A Phase 1 Non-Randomized Open Label Study of ICM20Status: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
New Chemotherapy Regimens and Biomarkers for Chagas DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-05-29
Clinical trial
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age: A Non-inferiority Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
Double Blind, Phase III Randomized,Safety and Efficacy Non-inferiority Trial to Evaluate Two Short Benznidazole Regimens for the Treatment of Adults in the Chronic Phase of Chagas Disease in Its Indeterminate and Mild Cardiac Forms in Bolivia and ColombiaStatus: Not yet recruiting, Estimated PCD: 2026-01-30
Clinical trial
Phase II Clinical Trial for the Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease in Adult Patients. Berenice ProjectStatus: Completed, Estimated PCD: 2020-09-21
Document
DailyMed Label: BenznidazoleOrganization
Exeltis USA, Inc.